RDNT vs ADPT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
RDNT · RadNet$69.71 ▲ 0.29%
ADPT · Adaptive Biotechnologies$27.93 ▼ 0.43%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- RDNT -17.5%
- ADPT +36.5%
Head to head
| Metric | RDNT | ADPT |
|---|---|---|
| Price | $69.71 | $27.93 |
| Change today | ▲ 0.29% | ▼ 0.43% |
| Market cap | $5.49B | $4.52B |
| Return, 3 months | -6.7% | +9.3% |
| Return, year to date | -2.3% | +72.0% |
| Return, 1 year | -16.0% | +50.1% |
| P/E (TTM) | – | – |
| P/B | 4.9 | 25.6 |
| P/E percentile vs own 5y | 27th | 4th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +22.1% | -10.7% |
| Net profit growth (YoY) | +37.9% | -70.6% |
| Gross margin | 11.5% | 74.2% |
| Operating margin | 4.1% | -16.2% |
| Net margin | -0.9% | -23.7% |
| Return on equity | -2.1% | -37.1% |
| Analyst target vs. price | +35.6% | +19.7% |
| Analyst buy share | 100% | 88% |
| RSI (14) | 39 | 52 |
| 30-day volatility | 42.6% | 55.7% |
| Max drawdown, 1 year | -38.6% | -39.3% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- RDNT is the largest of the group by market value.
- ADPT has returned the most over the past year.
- RDNT is growing revenue fastest.
- RDNT keeps the most profit per dollar of sales.
- RDNT has been the calmest stock over the last 30 days.